Israel Englander Plus Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.27 - $0.48 $18,153 - $32,272
-67,234 Reduced 49.11%
69,669 $20,000
Q4 2022

Feb 14, 2023
BUY
$0.3 - $8.4 $37,350 - $1.05 Million
124,500 Added 1003.79%
136,903 $43,000
Q3 2022

Nov 14, 2022
SELL
$0.48 - $7.5 $4,313 - $67,395
-8,986 Reduced 42.01%
12,403 $6,000

About PLUS THERAPEUTICS, INC.

PSTV Quotes by TradingView
  • Ticker PSTV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,601,400
  • Market Cap $40M
  • Description
  • Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...
More about PSTV
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email